IRIS
MAZZANTI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.538
NA - Nord America 3.706
AS - Asia 2.507
SA - Sud America 360
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 109
OC - Oceania 8
Totale 12.379
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.898
US - Stati Uniti d'America 3.591
CN - Cina 1.085
SG - Singapore 580
IE - Irlanda 503
HK - Hong Kong 282
BR - Brasile 257
RU - Federazione Russa 255
VN - Vietnam 209
NL - Olanda 192
DE - Germania 142
FR - Francia 130
FI - Finlandia 120
GB - Regno Unito 90
BD - Bangladesh 86
IN - India 70
CA - Canada 61
ZA - Sudafrica 57
AR - Argentina 43
SE - Svezia 33
JP - Giappone 31
MX - Messico 31
PL - Polonia 30
UA - Ucraina 30
TR - Turchia 23
AT - Austria 18
ES - Italia 17
VE - Venezuela 17
PK - Pakistan 15
IQ - Iraq 14
MA - Marocco 14
ID - Indonesia 13
PH - Filippine 13
BE - Belgio 12
CO - Colombia 12
IR - Iran 11
EC - Ecuador 10
SA - Arabia Saudita 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
LT - Lituania 9
CH - Svizzera 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
UZ - Uzbekistan 7
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
NP - Nepal 6
AU - Australia 5
BO - Bolivia 5
CL - Cile 5
GR - Grecia 5
IL - Israele 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
MD - Moldavia 4
NO - Norvegia 4
PS - Palestinian Territory 4
AL - Albania 3
AM - Armenia 3
CR - Costa Rica 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SC - Seychelles 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
ML - Mali 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AI - Anguilla 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
Totale 12.217
Salva come PNG Salva come JPEG
Città #
Dublin 497
San Jose 432
Milan 397
Chandler 373
Ashburn 340
Hong Kong 275
Singapore 271
Beijing 265
Rome 257
Dallas 248
Council Bluffs 198
Naples 147
Boardman 141
Nanjing 140
Los Angeles 96
Shanghai 93
Lauterbourg 88
New York 83
Turin 82
Helsinki 75
Princeton 74
San Genesio Ed Uniti 74
Ho Chi Minh City 70
Jacksonville 70
Lawrence 70
Florence 65
Medford 60
Moscow 59
Wilmington 59
Bari 56
Changsha 55
Hanoi 53
Nanchang 51
Palermo 51
Johannesburg 48
Bologna 46
Jiaxing 46
Hebei 44
Shenyang 43
Buffalo 40
Redondo Beach 39
Tianjin 38
Genoa 35
Munich 34
Reggio Emilia 34
Santa Clara 33
Catania 32
Parma 31
Cagliari 29
Hangzhou 27
Brescia 26
Orem 26
Ann Arbor 24
Montreal 24
Chicago 22
São Paulo 22
Atlanta 21
Pavia 20
The Dalles 20
Tokyo 20
Warsaw 20
Columbus 19
Padova 19
Messina 18
Pescara 18
Phoenix 18
London 17
Seattle 17
Turku 17
Verona 17
Woodbridge 17
Brooklyn 16
Chennai 16
Livorno 16
Modena 16
Norwalk 16
Nuremberg 16
San Francisco 16
Toronto 16
Frankfurt am Main 15
Pisa 14
Houston 13
Trieste 13
Imola 12
Taranto 12
Brussels 11
Monserrato 11
Stockholm 11
Venice 11
Haiphong 10
Mexico City 10
Mumbai 10
Pomigliano d'Arco 10
Da Nang 9
Denver 9
Manchester 9
Ravenna 9
Vienna 9
Bergamo 8
Cincinnati 8
Totale 6.738
Salva come PNG Salva come JPEG
Nome #
Sindrome di Brugada e idoneità alla mansione: case report 4.010
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 198
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 155
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 153
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 143
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 141
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 140
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 139
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 137
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 135
UceWeb: a Web-based Collaborative Tool for Collecting and Sharing Quality of Life Data. 129
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 129
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 125
Genetic causes of sudden cardiac death in the young. 123
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 123
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death] 122
Gquest: Modeling patient questionnaires and administering them through a mobile platform application 121
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 121
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). 116
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 115
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 114
Long-term follow-up of patients with short QT syndrome 113
Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis 111
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 110
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 109
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 106
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 104
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 101
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 99
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 98
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2 -Catecholaminergic Polymorphic Ventricular Tachycardia 95
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 94
"Ten Commandments" of 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 93
The genetics of Long QT Syndrome 92
Brugada syndrome and job fitness: report of three cases 91
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 90
Brugada Syndrome: The Endless Conundrum 90
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome 90
Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation: Personalized Medicine for Long QT Syndrome 89
Regulatory Light Chain (MYL2) Mutations in Familial Hypertrophic Cardiomyopathy 88
Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy? 88
Brugada syndrome and job fitness: report of three cases 87
Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome 87
Usefulness of exercise test in the diagnosis of short QT syndrome 86
Precision Medicine in Catecholaminergic Polymorphic Ventricular Tachycardia: JACC Focus Seminar 5/5 86
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 85
Arrhythmic Mitral Valve Prolapse: Introducing an Era of Multimodality Imaging-Based Diagnosis and Risk Stratification. 85
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 85
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator 83
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome 82
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 82
Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chain 81
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome 80
Nonmodifiable Risk Factors Predict Outcomes in Brugada Syndrome 80
Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy 80
Programmed Electrophysiological Stimulation for Risk Prediction in Patients with Brugada Syndrome: Closing Time?,La estimulacion electrica programada para la prediccion del riesgo en pacientes con sindrome de Brugada: ?tiempo de cierre? 79
Novel insights in the natural history of Short QT Syndrome 79
Molecular Autopsy for Sudden Unexplained Death? Time to Discuss Pros and Cons. 77
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome 77
Clinical Challenges in Catecholaminergic Polymorphic Ventricular Tachycardia 76
Reply: Did Mutation Type Affect the Efficacy of Mexiletine Observed in Patients With LQTS Type 3 75
Transmural APD heterogeneity determines ventricular arrhythmogenesis in LQT8 syndrome: Insights from Bidomain computational modeling 74
Benefit of Implantable Cardioverter-Defibrillators in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia - Reply 73
Genetic risk stratification in cardiac arrhythmias 73
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility 73
Indications for genetic testing in athletes and its indication in clinical practice 72
Characterization and Management of Arrhythmic Events in Young Patients With Brugada Syndrome 72
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply 72
Dilated cardiomyopathy 71
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 70
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 70
Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients 70
Unexpected impairment of INa current underpins reentrant arrhythmias in a knock-in swine model of Timothy syndrome 68
Real‐world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 67
Role of CACNA1C in Brugada syndrome: Prevalence and phenotype of probands referred for genetic testing 65
Genetic causes of sudden cardiac death in children: inherited arrhythmogenic diseases. 65
Inherited arrhythmias: LQTS/SQTS/CPVT 65
Is there a role for genetics in the prevention of sudden cardiac death? 64
Repeat adverse events long after percutaneous coronary revascularization in diabetics 64
Diagnosis of Long QT Syndrome: Time to Stand Up! 63
Los estudios genéticos en la prevención de la muerte súbita: ¿realidad o ficción? 63
Genotype-dependent differences in age of manifestation and arrhythmia complications in short QT syndrome 63
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization 61
Prevention of Sudden Death and Management of Ventricular Arrhythmias in Arrhythmogenic Cardiomyopathy 60
Short QT syndromes 60
Personalized therapies for cardiac channelopathies 59
Genetic Arrhythmias (Channelopathies) 59
Warning: Not All Carriers of Pathogenic Mutations in Desmosomal Genes Should Follow the Same Medical Advices! 59
Genotype-Phenotype Correlation of SCN5A Genotype in Patients With Brugada Syndrome and Arrhythmic Events: Insights From the SABRUS in 392 Probands 59
Risk Stratification in the Long QT Syndrome 58
Programmed electrophysiological stimulation for risk prediction in patients with Brugada syndrome: closing time? 54
The interpretation of genetic tests in inherited cardiovascular diseases 53
Characteristics of Patients with Spontaneous Versus Drug-Induced Brugada Electrocardiogram: Sub-Analysis From the SABRUS 51
Induction of ventricular fibrillation during programmed ventricular stimulation in a patient with CASQ2 heterozygous mutation 37
Totale 12.379
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 0 0 0 7 13 3 19 15 24 46 173
2022/20231.174 146 92 19 69 86 101 0 54 564 3 25 15
2023/20241.841 62 86 94 175 182 257 199 168 67 177 162 212
2024/20252.950 276 188 154 197 145 229 225 262 524 168 222 360
2025/20264.091 364 239 456 430 483 148 648 219 363 329 213 199
2026/2027993 186 241 336 230 0 0 0 0 0 0 0 0
Totale 12.379